Back

Effect of history of atrial arrhythmias on the rate of recurrent stroke in patients after PFO closure

18 April 2023 (11:55 - 13:15)
Organised by:
Congress Presentation Part of: ePoster session 46 Stroke in Atrial Fibrillation EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Otakar Jiravsky

Hospital Podlesi, Trinec (Czechia)

7 More presentations in this session

Presentation thumbnail
Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation
Doctor Y. Yamauchi (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Mechanisms for increased healthcare expenditures among patients with device detected atrial fibrillation
Doctor G. Peigh (Chicago, US)
Abstract Slides
Presentation thumbnail
Left atrial strain significance in prediction of early atrial fibrillation recurrence after cardioversion and ablation
Doctor N. Sabanovic-Bajramovic (Sarajevo, BA)
Abstract Slides
Presentation thumbnail
Temporal relation of disease onsets in patients with acute myocardial infarction and atrial fibrillation - results from a nationwide registry study
Miss E. Karlsson (Helsinki, FI)
Abstract Slides
Presentation thumbnail
New parameter of the second part of the P-wave predict atrial fibrillation: comparison with P-wave signal-averaged electrocardiography
Doctor Y. Lee (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 46

The Event

Event poster

EHRA 2023

18 April 2023 11:55 CET
You may be interested in
thumbnail
Congress Presentation
Standardized mortality ratio and long-term stroke recurrence after PFO-closure
31 August 2025
thumbnail
Congress Presentation
Recurrent paroxysmal atrial fibrillation that requires hospitalization: clinical and paraclinical profile
2 March 2019
thumbnail
Congress Presentation
Differences in left atrial functionality between individuals with ischemic stroke and healthy controls: a comparative analysis
25 April 2024
thumbnail
Congress Presentation
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources